Evidence map›Paper›PMID 39633683›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2024

Predicting severe COVID-19 using readily available admission indicators: SpO2/FiO2 ratio, comorbidity index, and gender.

Luan D Vu, Rebecca C Christofferson, Hollis R O'Neal, Diana Hamer, Anh T Q Phan, Katie M Vance, E A Turner, Avinash Kumar, Ibrahim Musa Yola, Natalie Lim and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Luan D VuDepartment of Biological Sciences, Louisiana State University and Pennington Biomedical Research Center, Baton Rouge, LA, United States.
Rebecca C ChristoffersonDepartment of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, United States.
Hollis R O'NealMedical Director of Research, Our Lady of the Lake Regional Medical Center, Pulmonary and Critical Care Medicine, Louisiana State University Health Sciences Center, Baton Rouge, LA, United States.
Diana HamerOffice of Research Administration, Our Lady of the Lake Regional Medical Center, Baton Rouge, LA, United States.
Anh T Q PhanDepartment of Biological Sciences, Louisiana State University and Pennington Biomedical Research Center, Baton Rouge, LA, United States.
Katie M VanceOffice of Research Administration, Our Lady of the Lake Regional Medical Center, Baton Rouge, LA, United States.
E A TurnerDepartment of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, United States.
Avinash KumarDepartment of Biological Sciences, Louisiana State University and Pennington Biomedical Research Center, Baton Rouge, LA, United States.
Ibrahim Musa YolaOffice of Research Administration, Our Lady of the Lake Regional Medical Center, Baton Rouge, LA, United States.
Natalie LimDepartment of Biological Sciences, Louisiana State University and Pennington Biomedical Research Center, Baton Rouge, LA, United States.
Beverly OgdenDepartment of Research, Woman's Hospital, Baton Rouge, LA, United States.
Stephania A CormierDepartment of Biological Sciences, Louisiana State University and Pennington Biomedical Research Center, Baton Rouge, LA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The focus of this study was to identify risk factors for severe and critical COVID-19, evaluate local respiratory immune responses to SARS-CoV-2 infection, and develop a prognostic tool for COVID-19 severity using accessible early indicators. Using nasopharyngeal swab samples from hospitalized patients with COVID-19 of varying severity during the first wave of the pandemic from March to May 2020 in Louisiana, we evaluated the association between COVID-19 severity and viral load, respiratory immune mediators, and demographic/clinical factors. We found that the SpO

Indexed as

ComorbidityCOVID-19SARS-CoV-2Severity of Illness IndexViral LoadAdultAgedFemaleHumansLouisianaMaleMiddle AgedOxygenOxygen SaturationPrognosisRisk FactorsOxygenCharlson Comorbidity IndexCOVID-19prognosticSARS-CoV-2severity

Identifiers

PMID39633683
PMCPMC11614601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.